[Differentiated quantitative serum protein determination during myocardial infarct].
D000328:Adult; D000917:Antibody Formation; D001798:Blood Proteins / Q000032:analysis*; D005455:Fluorescent Antibody Technique; D006023:Glycoproteins / Q000032:analysis; D006242:Haptoglobins / Q000032:analysis; D006801:Humans; D005779:Immunodiffusion; D008074:Lipoproteins / Q000032:analysis; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood* / Q000276:immunology; D012709:Serum Albumin / Q000032:analysis; D012712:Serum Globulins / Q000032:analysis; D013997:Time Factors; D014168:Transferrin / Q000032:analysis
D001798:Blood Proteins; D006023:Glycoproteins; D006242:Haptoglobins; D008074:Lipoproteins; D012709:Serum Albumin; D012712:Serum Globulins; D014168:Transferrin
Differenzierte quantitative Serumeiweissbestimmungen im Ablauf des Herzinfaktes.